Search Results

Business

Cellares Announces Agreement with Kite to Evaluate Its Cell Shuttle Automated Manufacturing Platform

Cellares today announced that Kite , a Gilead Company, will evaluate Cellares’ automated manufacturing platform, the Cell Shuttle.

June 27, 2024

·

2 min read

Press Releases

Cellares Appoints Ossama Eissa, Former Novartis, Lonza and Legend Biopharma Leader, as Chief Operating Officer

November 12, 2024

·

4 min read

Business

908 Devices and Cellares Collaborate to Integrate In-line Monitoring of Bioprocess Parameters into the Cell Shuttle, Cellares’ Fully Integrated Cell Therapy Manufacturing Platform

908 Devices Inc. and Cellares announce a development collaboration to integrate in-line monitoring of key cell culture parameters into Cellares’ Cell Shuttle system.

February 29, 2024

·

5 min read

Business

Cellarity Appoints Head of Platform to Advance Vision for Novel Drug Creation

Cellarity, a life sciences company founded by Flagship Pioneering to transform the way medicines are created, announced the appointment of Christopher Woelk, Ph.D., as Vice President and Head of Platform.

May 7, 2024

·

3 min read

Pictured: Bristol Myers Squibb office in California

Biotech Bay

BMS Taps Cellares in $380M CAR T Cell Therapy Manufacturing Agreement

Bristol Myers Squibb will be using Cellares’ Cell Shuttles, an automated production system capable of producing multiple cell therapies simultaneously, to potentially improve turnaround time to support the pharma’s CAR T cell therapies.

April 22, 2024

·

2 min read

·

Tyler Patchen

U.S. and Chinese flags in concrete, broken in the middle

Business

BMS-Cellares CAR-T Pact Highlights U.S.-China Biopharma Tensions

While Bristol Myers Squibb did not explicitly mention China as the company expands and diversifies its manufacturing capacity, Cellares said the BIOSECURE Act would be a boon to its own growth.

April 23, 2024

·

3 min read

·

Neil Versel

Business

Cellares and Cabaletta Bio Partner to Evaluate Automated Manufacturing for CABA-201, Cabaletta’s CD19-CAR T Cell Therapy on Cellares’ Cell Shuttle Platform

Cellares and Cabaletta Bio, Inc. today announced Cabaletta will evaluate Cellares’ automated manufacturing platform, the Cell Shuttle™, through Cellares’ Technology Adoption Partnership (TAP) program.

November 6, 2023

·

8 min read

Business

Christi Shaw, Former CEO of Kite, a Gilead Company, Appointed to Cellares Advisory Board to Advance Cell Therapy Manufacturing

Cellares, a leader in the automation of cell therapy manufacturing and the world’s first Integrated Development and Manufacturing Organization, announced the addition of Christi Shaw to its Advisory Board.

March 26, 2024

·

4 min read

Biotech Beach

Cellares and Lyell to Evaluate Automated Manufacturing of Lyell’s CAR T-Cell Therapy on Cellares’ Cell Shuttle Platform

Cellares and Lyell Immunopharma announced Lyell will evaluate Cellares’ automated manufacturing platform, the Cell Shuttle™, through Cellares’ Technology Adoption Partnership program.

September 11, 2023

·

8 min read

Genetown

Cellarity to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Cellarity Inc. announced today that Fabrice Chouraqui, CEO of Cellarity, will present a company overview, including recent business and research highlights, at the 42nd Annual J.P. Morgan Healthcare Conference at the Westin St. Francis on Thursday, January 11, 2024, at 7:30 a.m. PT.

January 3, 2024

·

1 min read